Armed with $180 million and a dual-acting antibody for eczema, the startup is capitalizing on a change in sentiment that’s ...
North Immunology is going public in a reverse merger with Aethlon Medical.
Aethlon Medical (AEMD) shares soared 346% premarket on Thursday as it agreed on an all-stock merger with North Immunology. The transaction, approved by both boards, is expected to close in the first ...
Orbis Medicines announced a strategic collaboration and license agreement with Novo to discover and develop next-generation ...
AbbVie (NYSE:ABBV) executives outlined a pipeline and business-development strategy centered on immunology, neuroscience, ...
Aethlon Medical (AEMD) stock jumped 471% after revealing merger with North Immunology, backed by $180M funding for atopic dermatitis drug development.
Aethlon Medical (AEMD) stock surged 471% after announcing an all-stock merger with North Immunology, backed by a $180M ...
Aethlon Medical, Inc. ( AEMD) shares are surging more than 470% after the company announced a definitive all-stock merger agreement with North Immunology, along with an oversubscribed $180 million ...
For people living with immune-mediated inflammatory diseases (IMIDs), symptoms can become part of daily life in ways that are often invisible to others. These diseases, which include conditions like ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results